MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

December 2011


Health Care and Law

Applying Legal Risk Management to the Clinical Use of Methadone

Methadone is gaining renewed interested as a therapy for chronic pain as well as for opioid dependence. The authors discuss safety concerns, two legal cases that resulted from patients’ deaths, and risk–management issues for P&T committees to ­consider.
James O’Donnell, PharmD, MS; and F. Randy Vogenberg, RPh, PhD

Meeting Highlights

62nd Annual Meeting of the American Association For the Study of Liver Diseases and American College of Rheumatology Annual Meeting

Topics covered at "Liver Week" included alisporivir and a protease inhibitor (BI 201335) for hepatitis C virus infection; everolimus for liver transplantation, and telaprevir in cirrhosis. The rheumatology sessions addressed the small molecule apremilast for psoriatic arthritis; etanercept for rheumatoid arthritis; and abatacept, adalimumab, etanercept, and infliximab in rheumatoid arthritis.
Walter Alexander

P&T Snapshot

A Survey of Oncology Trends

The Oncologist's Perspective

New findings reveal that patients with breast, prostate, and colon cancers are increasingly being treated in outpatient settings instead of hospitals; most cancer patients have early-stage disease upon diagnosis, except for Medicaid recipients; and oncologists have concerns about decreasing net profits.
Janice Zoeller and Peter Sonnenreich, MA

Continuing Education Credit

Newer Oral Atypical Antipsychotic Agents: A Review

Four second-generation antipsychotic medications — paliperidone (Invega), iloperidone (Fanapt), asenapine (Saphris), and lurasidone (Latuda) — may offer useful options for patients with schizophrenia, schizoaffective disorder, and bipolar ­disorder as well as depression.
Jonathan R. Scarff, MD; and David A. Casey, MD

Season’s Greetings

Thank you to our readers and reviewers


Medication Errors

Including Patients on Root Cause Analysis Teams: Pros and Cons

Matthew Grissinger, RPh, FASCP

Prescription: Washington

Final Rule on ACOs Raises Concerns About Medication Cost-Shifting

Pharmacists to Play a Secondary Role in New Physician–Hospital Organizations

Hospital pharmacists will be dealing with the fallout from cost-shifting in ACOs — with none of the benefits
Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Deferiprone (Ferriprox) for iron overload after blood transfusions; and ezogabine (Potiga) for partial-onset seizures
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Efficacy and Safety of Linagliptin (Tradjenta) in Adults With Type-2 Diabetes Mellitus

Linagliptin (Tradjenta) for type-2 diabetes mellitus
Maisha Kelly Freeman, PharmD, MS, BCPS